US Dominates the Personalized Medicine Market
According to a new research report by RNCOS entitled, “Personalized Medicine Market Analysis”, US dominates the personalized medicine market and is backed by robust innovations and advancements. Representing the largest share in the global pie, the market for personalized medicine in US and is anticipated to grow at a CAGR of around 9.5% during 2012-2017. The need for rapid detection of diseases especially cancer and more efficient treatments are primarily driving this market. Personalized medicine has evolved primarily in the...
View full press release